Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Zimmer

Showing results (51-60 of 342) with videos related to

Pageof 35
Sort By:
Behavioural Brain Research|May 5, 2010
Modulation of the CRH system by substance P/NKA in an animal model of depressionPamela Frisch, András Bilkei-Gorzó, Ildiko Rácz, et al.
Molecular Cancer|June 10, 2017
ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cellsGiulia Cesi, Geoffroy Walbrecq, Andreas Zimmer, et al.
Neuroreport|December 1, 2005
Visceral, inflammatory and neuropathic pain in glycine receptor alpha 3-deficient miceIldikó Rácz, Burkhard Schütz, Osama M Abo-Salem, et al.
Neurochemistry International|May 23, 2012
Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptorsFerenc Zádor, Ferenc Otvös, Sándor Benyhe, et al.
International Journal of Pharmaceutics|February 21, 2012
Effect of protamine on the solubility and deamidation of human growth hormoneElisabeth Ablinger, Stefan Wegscheider, Walter Keller, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 22, 2008
In vitro release of propofol and binding capacity with regard to plasma constituentsMaximilian Schicher, Margit Polsinger, Albin Hermetter, et al.
Crystal Growth & Design|March 14, 2014
Morphologies in Solvent-Annealed Clotrimazole Thin Films Explained by Hansen-Solubility ParametersHeike M A Ehmann, Andreas Zimmer, Eva Roblegg, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 26, 2012
Clinical potential of VIP by modified pharmaco-kinetics and delivery mechanismsBernhard Burian, Anna Ortner, Ruth Prassl, et al.
Molecular Membrane Biology|December 24, 2005
Functional characterization of P2X3 receptors fused with fluorescent proteinsAlexander Grote, Zsolt Boldogkoi, Andreas Zimmer, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2005
Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterizationDirk Lochmann, Jörg Weyermann, Christiane Georgens, et al.
Pageof 35

Showing results (51-60 of 342) with videos related to

Sort By:
Pageof 35
Behavioural Brain Research|May 5, 2010
Modulation of the CRH system by substance P/NKA in an animal model of depressionPamela Frisch, András Bilkei-Gorzó, Ildiko Rácz, et al.
Molecular Cancer|June 10, 2017
ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cellsGiulia Cesi, Geoffroy Walbrecq, Andreas Zimmer, et al.
Neuroreport|December 1, 2005
Visceral, inflammatory and neuropathic pain in glycine receptor alpha 3-deficient miceIldikó Rácz, Burkhard Schütz, Osama M Abo-Salem, et al.
Neurochemistry International|May 23, 2012
Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptorsFerenc Zádor, Ferenc Otvös, Sándor Benyhe, et al.
International Journal of Pharmaceutics|February 21, 2012
Effect of protamine on the solubility and deamidation of human growth hormoneElisabeth Ablinger, Stefan Wegscheider, Walter Keller, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 22, 2008
In vitro release of propofol and binding capacity with regard to plasma constituentsMaximilian Schicher, Margit Polsinger, Albin Hermetter, et al.
Crystal Growth & Design|March 14, 2014
Morphologies in Solvent-Annealed Clotrimazole Thin Films Explained by Hansen-Solubility ParametersHeike M A Ehmann, Andreas Zimmer, Eva Roblegg, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 26, 2012
Clinical potential of VIP by modified pharmaco-kinetics and delivery mechanismsBernhard Burian, Anna Ortner, Ruth Prassl, et al.
Molecular Membrane Biology|December 24, 2005
Functional characterization of P2X3 receptors fused with fluorescent proteinsAlexander Grote, Zsolt Boldogkoi, Andreas Zimmer, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2005
Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterizationDirk Lochmann, Jörg Weyermann, Christiane Georgens, et al.
Pageof 35